0001209191-18-039416.txt : 20180625
0001209191-18-039416.hdr.sgml : 20180625
20180625165157
ACCESSION NUMBER: 0001209191-18-039416
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20180625
DATE AS OF CHANGE: 20180625
EFFECTIVENESS DATE: 20180625
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cerebral Therapeutics, Inc.
CENTRAL INDEX KEY: 0001744709
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-315333
FILM NUMBER: 18917522
BUSINESS ADDRESS:
STREET 1: 12635 E. MONTVIEW BLVD.
CITY: AURORA
STATE: CO
ZIP: 840010
BUSINESS PHONE: 3035473448
MAIL ADDRESS:
STREET 1: 12635 E. MONTVIEW BLVD.
CITY: AURORA
STATE: CO
ZIP: 840010
D
1
primary_doc.xml
X0708
D
LIVE
0001744709
Cerebral Therapeutics, Inc.
12635 E. Montview Blvd.
Aurora
CO
COLORADO
80010
3035473448
DELAWARE
Cerebral Therapeutics, LLC
None
Corporation
true
Daniel
Abrams
12635 E. Montview Blvd.
Aurora
CO
COLORADO
80010
Executive Officer
Director
Chief Executive Officer
Mahendra
Shah
505 Hamilton Ave.
Suite 207
Palo Alto
CA
CALIFORNIA
94301
Director
Warren
Lammert
109 State Street
5th Floor
Boston
MA
MASSACHUSETTS
02109
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2018-06-11
true
true
true
false
0
7000000
2500000
4500000
false
2
0
0
0
false
Cerebral Therapeutics, Inc.
/s/ Daniel J. Abrams, MD
Daniel J. Abrams, MD
Chief Executive Officer
2018-06-20